H. Universitario Marqués de Valdecilla

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma3 trials

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• PETHEMA Foundation3 trials

Running trials

• Not yet recruiting

  Elranatamab With Mezigdomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

  NCT07901868· Phase 2· PETHEMA Foundation· Source

  Contact: Alfonso Santiago, PhD

• Active, not recruiting

  Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma

  NCT05849610· Phase 2· PETHEMA Foundation· Source

• Recruiting

  NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide

  NCT05558319· Phase 3· PETHEMA Foundation· Source

  Contact: Enrique Ocio

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma2 recruiting